Clinical Trial

Combined Movement and Storytelling Intervention on Physical Performance in Children

Study acronym: CMSI&Child
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated September 14, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study protocol aims to analyze and compare the effects of combined movement and storytelling intervention (CMSI) on fundamental motor skills (locomotor skills and object control), language development (language comprehension, language expression, vocabulary and language description), and physical activity levels (light, moderate to vigorous intensity, and sedentary time) in children aged 3 to 6 years. The sample will consist of 144 children of 12 classes group, randomly assigned to 3 experimental groups (n= 72 children) and 3 control groups (n= 72 children), belonging to 4 classes group of upper middle level classes (2 experimental and 2 control), 4 transition level 1 classes (2 experimental and 2 control) and 4 transition level 2 classes (2 experimental and 2 control). The experimental groups will perform the CMSI for 3 sessions (40-minute per session) per week over 12-weeks (using one motor story per week), while the control groups will not receive any treatment. The main outcome will provide information about fundamental motor skills, language development, and physical activity levels. It is hypothesized that the CMSI has the potential to generate significant increases in selected assessments. If this intervention proves to be beneficial, if could contribute to preschoolers children curricula.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-25.
Status change: Not Yet Recruiting → Recruiting 2024-08-06
Trial Details
NCT Number NCT06016296
Lead Sponsor Universidad Católica del Maule
Conditions Preschool Children
Enrollment 144 participants
Start Date 2024-03-14
Primary Completion 2024-09-14 (estimated)
Study Completion 2025-04-15 (estimated)
Updated on ClinicalTrials.gov 2024-08-09